Calmodulin regulation of basal agonist-stimulated g protein coupling by the μ-opioid receptor (OP3) in morphine-pretreated cells

Journal of Neurochemistry

Volumn 75, Issue 2, 2000, Pages 763-771

  Wang, Danxin ^a   Surratt, Christopher K ^b   Sadée, Wolfgang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Opioid receptor; Calmodulin; Desensitization; Morphine; Sensitization

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; CALMIDAZOLIUM; CALMODULIN; CALMODULIN INHIBITOR; CHLORMETHINE; CHLORNALTREXAMINE; FLUPHENAZINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PHOSPHOTRANSFERASE INHIBITOR;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; ANIMALS; CALMODULIN; CELL LINE; CELL MEMBRANE; CHICKENS; EGTAZIC ACID; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; KIDNEY; KINETICS; MORPHINE; MUTAGENESIS, SITE-DIRECTED; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, MU; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0033944274     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750763.x     Document Type: Article

References (43)

1. Afify E. A., Law P. Y., Riedl M., Elde R., and Loh H. H. (1998) Role of carboxyl terminus of μ-and δ-opioid receptor in agonist-induced down-regulation. Mol. Brain Res. 54, 24-34.
2. Arden J. R., Segredo F., Wang Z. J., Lameh J., and Sadée W. (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65, 1636-1645.
3. Baram D. and Simantov R. (1983) Enkephalins and opiate antagonists control calmodulin distribution in neuroblastoma-glioma cells. J. Neurochem. 40, 55-63.
4. Blake A. D., Bot G., Freeman J. C., and Reisine T. (1997) Differential opioid agonist regulation of the mouse μ opioid receptor. J. Biol. Chem. 272, 782-790.
5. Breivogel C. S., Selley D. E., and Childers S. R. (1997) Acute and chronic effects of opioids on δ and μ receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes. J. Neurochem. 68, 1462-1472.
6. Burd A. L., El-Kouhen R., Erickson L. J., Loh H. H., and Law P. Y. (1998) Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the μ-opioid receptor. J. Biol. Chem. 273, 34488-34495.
7. Burford N. T., Tolbert L. M., and Sadée W. (1998) Specific G protein activation and μ-opioid receptor internalization caused by morphine, DAMGO and endomorphin I. Eur. J. Pharmacol. 342, 123-126.
8. Chiu T. T., Yung L. Y., and Wong Y. H. (1996) Inverse agonistic effect of ICI-174,864 on the cloned δ-opioid receptor: role of G protein and adenylyl cyclase activation. Mol. Pharmacol. 50, 1651-1657.
9. Collier H. O. (1980) Cellular site of opiate dependence. Nature 283, 625-629.
10. Crain S. M. and Shen K. F. (1992) After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res. 575, 13-24.
11. Fan G. H., Wang L. Z., Qiu H. C., Ma L., and Pei G. (1999) Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharmacol. 56, 39-45.
12. Ferguson S. S. G., Downey W. E., Colapietro A. M., Barak L. S., Menard L., and Caron M. G. (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271, 363-366.
13. Gucker S. and Bidlack J. M. (1992) Protein kinase C activation increases the rate and magnitude of agonist-induced δ-opioid receptor down-regulation in NG108-15 cells. Mol. Pharmacol. 42, 656-665.
14. 2+/calmodulin-dependent protein kinase II: comparative study of the phosphorylation sites. Arch. Biochem. Biophvs. 278, 41-45.
15. Koch T., Kroslak T., Mayer P., Raulf E., and Höllt V. (1997) Site mutation in the rat μ-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization. J. Neurochem. 69, 1767-1770.
16. Koob G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 177-184.
17. Koob G. F. and LeMoal M. (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278, 52-58.
18. Kreek M. J. (1996) Opiates, opioids and addiction. Mol. Psychiatry 1, 232-254.
19. 2+/ calmodulin-dependent protein kinase II. Proc. Natl. Acad. Sdci. USA 83, 4253-4257.
20. Lukas T. J., Burgess W. H., Prendergast F. G., Lau W., and Watterson D. M. (1986) Calmodulin binding domains: characterization of a phosphorylation and calmodulin binding site from myosin light chain kinase. Biochemistry 25, 1458-1464.
21. 2+-triggered molecular switch. Cell 44, 861-870.
22. Nehmad R., Nadler H., and Simantov R. (1982) Effects of acute and chronic morphine treatment of calmodulin activity of rat brain. Mol. Pharmacol. 22, 389-394.
23. Nestler E. J. (1993) Cellular responses to chronic treatment with drugs of abuse. Crit. Rev. Neurobiol. 7, 23-39.
24. Noble F. and Cox B. M. (1996) Differential desensitization of μ-and δ-opioid receptors in selected neural pathways following chronic morphine treatment. Br. J. Pharmacol. 117, 161-169.
25. Pak Y., O'Dowd B. F., and George S. R. (1997) Agonist-induced desensitization of the μ opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J. Biol. Chem. 272, 24961-24965.
26. Pak Y., O'Dowd B. F., Wang J. B., and George S. R. (1999) Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor - the receptor is a direct substrate for protein-tyrosine kinase. J. Biol. Chem. 274, 27610-27616.
27. Pei G., Kieffer B. L., Lefkowitz R. J., and Freedman N. J. (1995) Agonist-dependent phosphorylation of the δ-opioid receptor -involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48, 173-177.
28. Polakiewicz R. D., Schieferl S. M., Dorner L. F., Kansra V., and Comb M. J. (1998) A mitogen-activated protein kinase pathway is required for μ-opioid receptor desensitization. J. Biol. Chem. 273, 12402-12406.
29. Sharma S. K., Klee W. A., and Nirenberg M. (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72, 3092-3096.
30. Shen K. F. and Crain S. M. (1992) Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance. Brain Res. 597, 74-83.
31. Thompson W. J. and Appleman M. M. (1971) Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10, 311-316.
32. Ueda H., Miyamae T., Fukushima N., and Misu Y. (1994) Protein kinase inhibitor potentiates opioid delta-receptor currents in Xenopus oocytes. Neuroreport 5, 1985-1988.
33. Wang D., Sadée W., and Quillan J. M. (1999) Calmodulin binding to G protein-coupling domain of opioid receptors. J. Biol. Chem. 274, 22081-22088.
34. 3) receptor. J. Neurohem. 74, 1418-1425.
35. Wang L. and Gintzler A. R. (1995) Morphine tolerance and physical dependence - reversal of opioid inhibition to enhancement of cyclic AMP formation. J. Neurochem. 64, 1102-1106.
36. Wang Z., Bilsky E. J., Porreca F., and Sadée W. (1994) Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci. 54, PL339-PL350.
37. 2+-dependent. FEBS Lett. 387, 53-57.
38. Way E. L., Loh H. H., and Shen F. H. (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167, 1-8.
39. Whistler J. L., Chuang H. H., Chu P., Jan L. Y., and von Zastrow M. (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23, 737-746.
40. Yabaluri N. and Medzihradsky F. (1997) Down-regulation of μ-opioid receptor by full but not partial agonists is independent of G protein coupling. Mol. Pharmacol. 52, 896-902.
41. Yu Y. K., Zhang L., Yin X. X., Sun H., Uhl G. R., and Wang J. B. (1997) μ opioid receptor phosphorylation, desensitization, and ligand efficacy. J. Biol Chem. 272, 28869-28874.
42. Zhang J., Ferguson S. S. G., Barak L. S., Bodduluri S. R., Laporte S. A., Law P. Y., and Caron M. G. (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc. Natl. Acad. Sci. USA 95, 7157-7162.
43. Zhang L., Yu Y. K., Mackin S., Weight F. F., UhI G. R., and Wang J. B. (1996) Differential μ opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271, 11449-11454.